Viewing Study NCT06074692


Ignite Creation Date: 2025-12-24 @ 3:28 PM
Ignite Modification Date: 2026-01-03 @ 6:50 PM
Study NCT ID: NCT06074692
Status: RECRUITING
Last Update Posted: 2023-10-31
First Post: 2023-10-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA)
Sponsor: Ruijin Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module